Corcept Therapeutics Incorporated (CORT) institutional holders · P/E 191, rev $761.4M
Corcept Therapeutics Incorporated 13F cache, top 3 holders by reported value. Each row is the filer's newest cached 13F for quarters ended 2026-06-30 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Filers whose newest cached 13F is older are omitted.
| Holder | Shares | Value | Report |
|---|---|---|---|
| FMR LLC | 3,337,618 | $290.2M | 2026-06-30 |
| STATE STREET CORP | 3,279,381 | $285.2M | 2026-06-30 |
| Bridgewater Associates, LP | 57,602 | $5.0M | 2026-06-30 |
CORT institutional holders FAQ
How many CORT 13F holders are listed on this page?
This page lists 3 cached Corcept Therapeutics Incorporated (CORT) 13F holders. Holders: https://lician.com/institutional/cort
Who is the largest CORT 13F holder by reported value?
The largest cached 13F holder by reported value on this page is FMR LLC. Filer: https://lician.com/institutional/cort/315066. Holders: https://lician.com/institutional/cort
What value and shares did the largest CORT 13F holder report?
FMR LLC, the largest cached 13F holder by reported value on this page, reported 3,337,618 shares and a value of $290.2M.
What is the latest CORT 13F report date on this page?
The latest cached 13F report date on this Corcept Therapeutics Incorporated (CORT) holders table is Jun 30, 2026.
Which CORT 13F holders report the largest positions?
The largest cached 13F holders by reported value on this Corcept Therapeutics Incorporated (CORT) page are FMR LLC, STATE STREET CORP, and Bridgewater Associates, LP. Holders: https://lician.com/institutional/cort
Where are CORT institutional holders listed?
Cached 13F holders for Corcept Therapeutics Incorporated (CORT) are listed at https://lician.com/institutional/cort. Filer directory: https://lician.com/holders
What is CORT's P/E ratio?
Corcept Therapeutics Incorporated (CORT) trailing P/E is 190.8 on the latest cached fundamentals snapshot.
What is CORT's latest revenue?
Latest cached Corcept Therapeutics Incorporated (CORT) revenue for Dec 31, 2025 was $761.4M. Statements: https://lician.com/financials/cort
Not investment advice. Cached rows, not a live tape.